Peter Hagell
101 – 110 of 154
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Respondent burden and patient-perceived validity of the PDQ-39.
- Contribution to journal › Article
-
Mark
Status of neural repair clinical trials in brain diseases
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Dyskinesia and neural grafting in Parkinson's disease
(2006) p.184-224
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
The significance of importance: an evaluation of ferrans and powers' quality of life index.
- Contribution to journal › Article
- 2005
-
Mark
Factors affecting the clinical outcome after neural transplantation in Parkinson's disease
- Contribution to journal › Article
-
Mark
Feasibility and linguistic validity of the Swedish version of the PDQ-39
- Contribution to journal › Article
-
Mark
Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical perspective.
- Contribution to journal › Article
-
Mark
Apomorphine in Parkinson's disease
(2005)
- Book/Report › Book
-
Mark
Future developments in the treatment of Parkinson’s disease
(2005) p.201-201
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Diagnosing Parkinson’s disease
(2005) p.9-9
- Chapter in Book/Report/Conference proceeding › Book chapter
